Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am J Kidney Dis. 2017 Jun 9;70(3):357–367. doi: 10.1053/j.ajkd.2017.04.021

Table 1.

Baseline characteristics stratified by urine ACR

Variable Total
(N=2707)
ACR <10 mg/g
(n=1386)
ACR 10−29 mg/g
(n=776)
ACR 30−299 mg/g
(n=466)
ACR ≥300 mg/g
(n=79)
P for Trend
Demographic Characteristics
 Age (years) 68.4 (8.6) 67.1 (8.1) 69.5 (8.6) 69.9 (9.3) 70.9 (8.9) <0.001
 Female sex 994 (36.7%) 469 (33.8%) 342 (44.1) 153 (32.8%) 30 (38%) <0.001
 Race/Ethnicity 0.8
  White 1600 (59.1%) 803 (57.9%) 475 (61.2%) 281 (60.3%) 41 (52%)
  Black 824 (30.4%) 451 (32.5%) 205 (26.4%) 138 (29.6%) 30 (38%)
  Hispanic 225 (8.3%) 104 (7.5%) 75 (9.7%) 40 (8.6%) 6 (8%)
  Other 58 (2.1%) 28 (2.0%) 21 (2.7%) 7 (1.5%) 2 (3%)
 Education 0.09
  Below HS Graduate 227 (8.4%) 111 (8.0%) 71 (9.2%) 34 (7.3%) 11 (14%)
  HS Graduate 456 (16.9%) 220 (15.9%) 136 (17.5%) 84 (18.0%) 16 (20%)
  Beyond HS 2024 (74.8%) 1055 (76.2%) 569 (73.3%) 348 (74.7%) 52 (66%)
Medical History
 Cardiovascular Disease 543 (20.1%) 247 (17.8%) 163 (21.0%) 109 (23.4%) 24 (30%) 0.004
 Diabetes History 38 (1.4%) 16 (1.2%) 13 (1.7%) 5 (1.1%) 4 (5%) 0.03
 Hypertension 2538 (93.8%) 1284 (92.6%) 727 (93.7%) 448 (96.1%) 79 (100%) 0.005
 Smoking 0.3
  Never 1181 (43.7%) 618 (44.7%) 347 (44.8%) 185 (39.7%) 31 (39%)
  Former 1184 (43.8%) 604 (43.6%) 324 (41.8%) 218 (46.8%) 38 (48%)
  Current 339 (12.5%) 162 (11.7%) 104 (13.4%) 63 (13.5%) 10 (13%)
Hypertension Medications
 ACE inhibitor 1004 (37.1%) 495 (35.7%) 298 (38.4%) 174 (37.3%) 37 (47%) 0.2
 ARB 584 (21.6%) 315 (22.7%) 148 (19.1%) 104 (22.3%) 17 (22%) 0.3
 Calcium channel blocker 966 (35.7%) 422 (30.5%) 292 (37.6%) 214 (45.9%) 38 (48%) <0.001
 B-blocker 845 (31.2%) 379 (27.3%) 257 (33.1%) 171 (36.7%) 38 (48%) <0.001
 Diuretic 1208 (44.6%) 635 (45.8%) 346 (44.6%) 187 (40.1%) 40 (51%) 0.1
Clinical Results
 Systolic BP (mm Hg) 138.8 (16.0) 136.24 (14.7) 140.7 (16.3) 142.1 (17.0) 145.9 (20.6) <0.001
 Diastolic BP (mm Hg) 77.3 (11.8) 77.27 (10.9) 76.9 (12.1) 78.1 (13.1) 78.7 (14.5) 0.3
 BMI (kg/m2) 29.8 (5.7) 29.89 (5.4) 29.6 (5.8) 30.2 (6.1) 29.4 (5.8) 0.3
Laboratory Results
 Urine ACR (mg/g) 9.7 (5.7, 22.5) 5.8 (4.4, 7.6) 15.1 (12.2, 20.0) 59.5 (40.0, 105.0) 475.0 (382.4, 961.9) <0.001
 eGFR (ml/min/1.73m2) 70.8 (20.9) 73.4 (18.3) 72.0 (21.5) 63.7 (24.0) 53.8 (20.7) <0.001
 Cholesterol
  Total (mg/dL) 189.9 (41.1) 191.6 (39.9) 191.3 (42.6) 183.2 (41.5) 186.1 (42.9) 0.001
  HDL (mg/dL) 53.4 (14.5) 53.1 (13.7) 54.7 (15.4) 51.5 (15.0) 55.1 (15.8) 0.001
  LDL (mg/dL) 112.3 (35.4) 115.0 (34.3) 111.6 (36.6) 106.6 (35.7) 104.9 (35.7) <0.001
 Triglycerides (mg/dL) 122.4 (71.1) 118.2 (62.4) 125.8 (80.8) 128.0 (76.4) 128.8 (76.3) 0.02

Note: Values for categorical variables are given as number (percentage); values for continuous variables, as mean ± standard deviation or median [interquartile range]. Conversion factors for units: cholesterol in mg/dL to mmol/L, ×0.02586; triglycerides in mg/dL to mmol/L, ×0.01129; ACR in mg/g to mg/mmol, ×0.113).

HS, high school; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BP, blood pressure; BMI, body mass index; ACR, albumin-creatinine ratio; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein.